Zobrazeno 1 - 10
of 33
pro vyhledávání: '"C. C. Sigman"'
Autor:
V. E. Steele, D. Bagheri, D. A. Balentine, C. W. Boone, R. Mehta, M. A. Morse, S. Sharma, C. C. Sigman, G. D. Stoner, M. J. Wargovich, J. H. Weisburger, S. Zhu, G. J. Kelloff
Publikováno v:
Experimental Biology and Medicine. 220:210-212
Autor:
G. J. Kelloff, C. C. Sigman
Publikováno v:
Mechanisms in Carcinogenesis and Cancer Prevention ISBN: 9783642078590
The potential role of products of arachidonic acid (AA) metabolism in carcinogenesis has been reviewed extensively (Kelloff et al. 1994; Marnett 1995; Taketo 1998a,b; Dannenberg et al. 2001; Funk 2001), as have cancer prevention strategies based on m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c4501b2f3ba3d6aba872f397694d9c8
https://doi.org/10.1007/978-3-662-08602-5_11
https://doi.org/10.1007/978-3-662-08602-5_11
Publikováno v:
IARC scientific publications. 154
Relevant and feasible surrogate end-points are needed for the evaluation of intervention strategies against cancer and other chronic, life-threatening diseases. Carcinogenesis can be viewed as a process of progressive disorganization. This process is
Publikováno v:
Carcinogenesis. 21(7)
Retinoids are essential for the maintenance of epithelial differentiation. As such, they play a fundamental role in chemoprevention of epithelial carcinogenesis and in differentiation therapy. Physiological retinoic acid is obtained through two oxida
Publikováno v:
European journal of cancer (Oxford, England : 1990). 35(14)
Cancer chemoprevention is the use of agents to inhibit, delay or reverse carcinogenesis. The focus of chemoprevention research in the next millennium will include defining the genotypic and phenotypic (functional and histological) changes during carc
Autor:
G J, Kelloff, C C, Sigman, K M, Johnson, C W, Boone, P, Greenwald, J A, Crowell, E T, Hawk, L A, Doody
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(2)
This paper proposes a scientific basis and possible strategy for applying surrogate end points in chemopreventive drug development. The potential surrogate end points for cancer incidence described are both phenotypic (at the tissue, cellular, and mo
Autor:
V E, Steele, C A, Holmes, E T, Hawk, L, Kopelovich, R A, Lubet, J A, Crowell, C C, Sigman, G J, Kelloff
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 8(5)
Mounting evidence suggests that lipoxygenase (LO)-catalyzed products have a profound influence on the development and progression of human cancers. Compared with normal tissues, significantly elevated levels of LO metabolites have been found in lung,
Publikováno v:
Clinical chemistry. 44(2)
Recently, several promising strategies have been advanced for improving the efficiency of new agent development. These include pharmacokinetic/pharmacodynamic (PK/PD) and intermediate endpoint biomarker (IEB) monitoring. Here, we review their essenti
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 6(4)
Among the most important targets for chemopreventive intervention and drug development are deregulated signal transduction pathways. Ras proteins serve as central connectors between signals generated at the plasma membrane and nuclear effectors; thus
Autor:
G J, Kelloff, E T, Hawk, J E, Karp, J A, Crowell, C W, Boone, V E, Steele, R A, Lubet, C C, Sigman
Publikováno v:
Seminars in oncology. 24(2)
Chemoprevention has four goals: (1) inhibition of carcinogens, (2) logical intervention for persons at genetic risk for cancer, (3) treatment of precancerous lesions, and (4) confirmation and translation of leads from dietary epidemiology into interv